Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhanced Detection of Acute Ischemic Stroke With Low-Field MRI.

Stroke (Hoboken, N.J.)·2026
Same author

2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association.

Stroke·2026
Same author

Endovascular Treatment of Stroke Due to Medium-Vessel Occlusion.

The New England journal of medicine·2025
Same author

Small Step or Giant Leap? Expanding the Acute Stroke Thrombolysis Window to 24 Hours.

The New England journal of medicine·2024
Same author

Thrombolysis of stroke mimics via telestroke.

Stroke and vascular neurology·2022
Same author

Global Impact of COVID-19 on Stroke Care and IV Thrombolysis.

Neurology·2021
Same journal

Overview of Novel Mechanisms in Obesity Pharmacotherapy and Implications for Cardiovascular Disease: A Narrative Review.

Current atherosclerosis reports·2026
Same journal

Artificial and Other Non-Nutritive Sweeteners, the Microbiome, and Cardiometabolic Health.

Current atherosclerosis reports·2026
Same journal

Single-cell Technologies in Atherosclerosis: Uncovering Cellular Heterogeneity, Mechanisms, and Therapeutic Opportunities.

Current atherosclerosis reports·2026
Same journal

Primary Prevention of Dyslipidemia: 10 Practice-Changing Takeaways from the 2026 ACC/AHA Multisociety Guideline.

Current atherosclerosis reports·2026
Same journal

Comparative Efficacy of Nutraceuticals on Endothelial Function: A Systematic Review and Network Meta-Analysis.

Current atherosclerosis reports·2026
Same journal

Familial Hypercholesterolemia in Women: Diagnosis, Treatment, and Cardiovascular Outcomes Across the Lifespan.

Current atherosclerosis reports·2026
See all related articles

Related Experiment Video

Updated: Apr 10, 2026

Closure of a Patent Foramen Ovale PFO: An Intervention Sequence
10:52

Closure of a Patent Foramen Ovale PFO: An Intervention Sequence

Published on: December 23, 2022

7.1K

PFO Closure for Cryptogenic Stroke.

Sabreena J Gillow1, Vivien H Lee

  • 1Department of Neurological Sciences, Section of Cerebrovascular Disease, Rush University Medical Center, 1725 W. Harrison St #1121, Chicago, IL, 60612, USA, Sabreena_J_Gillow@rush.edu.

Current Atherosclerosis Reports
|June 17, 2015
PubMed
Summary
This summary is machine-generated.

Patent foramen ovale (PFO) is linked to cryptogenic stroke. While closure is common, few trials assess its effectiveness in preventing future ischemic events.

More Related Videos

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
07:41

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

4.5K
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.8K

Related Experiment Videos

Last Updated: Apr 10, 2026

Closure of a Patent Foramen Ovale PFO: An Intervention Sequence
10:52

Closure of a Patent Foramen Ovale PFO: An Intervention Sequence

Published on: December 23, 2022

7.1K
Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
07:41

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

4.5K
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.8K

Area of Science:

  • Cardiology
  • Neurology
  • Vascular Medicine

Background:

  • Patent foramen ovale (PFO) is a common cardiac anomaly.
  • PFO is a potential pathway for paradoxical embolism causing ischemic stroke.
  • The association between PFO and cryptogenic stroke remains debated, particularly in younger patients.

Purpose of the Study:

  • To review the current understanding of PFO as a mechanism for ischemic stroke.
  • To discuss the evolving treatment strategies for PFO, including closure interventions.
  • To highlight the limited evidence from randomized controlled trials on PFO closure efficacy for stroke prevention.

Main Methods:

  • Literature review of studies investigating PFO and stroke.
  • Analysis of traditional and contemporary treatment approaches for PFO.
  • Assessment of the existing randomized controlled trial data on PFO closure.

Main Results:

  • PFO is frequently found in the general population.
  • Antithrombotic therapy has been the traditional management for PFO-associated stroke risk.
  • Transcatheter and surgical PFO closure are increasingly used, but robust trial data is scarce.

Conclusions:

  • The role of PFO in cryptogenic stroke is still under investigation.
  • Further high-quality randomized controlled trials are needed to establish the efficacy of PFO closure for stroke prevention.
  • Evidence-based guidelines for PFO management in stroke patients require strengthening.